Acebrophylline 200 mg (Sustained Release) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Acebrophylline 200 mg (Sustained Release) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Mucolytic + Bronchodilator SR
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Acebrophylline 200 mg (Sustained Release) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Acebrophylline 200 mg (Sustained Release) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Acebrophylline 200 mg (Sustained Release) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Acebrophylline 200 mg (Sustained Release) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Chronic COPD maintenance
- Bronchial asthma (once-daily)
- Bronchiectasis (chronic)
Mechanism of Action
Acebrophylline is a complex of ambroxol and theophylline-7-acetate — providing combined mucolytic effect (ambroxol component: stimulates surfactant, depolymerises mucus mucopolysaccharide fibres) and PDE-inhibitor bronchodilation (theophylline component). Used for COPD, chronic bronchitis, and asthma with thick mucus.
Dosage & Administration
- Adults: 200 mg SR once or twice daily.
Side Effects
- Tremor, palpitations, tachycardia (xanthine effects), nausea, GI upset, headache.
Contraindications
- Severe cardiac arrhythmia, severe peptic ulcer, hyperthyroidism, seizure disorders, severe hepatic impairment.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Acebrophylline 200 mg (Sustained Release) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Acebrophylline 200 mg (Sustained Release) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Acebrophylline 200 mg (Sustained Release) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Acebrophylline 200 mg (Sustained Release) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Acebrophylline 200 mg (Sustained Release) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Acebrophylline 200 mg (Sustained Release) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Acebrophylline 200 mg (Sustained Release) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Acebrophylline 200 mg (Sustained Release) Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Acebrophylline 200 mg (Sustained Release) Tablet?
MRPs range from ₹1644 to ₹1644 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Acebrophylline 200 mg (Sustained Release) Tablet?